146 related articles for article (PubMed ID: 3873304)
41. Autoantibodies to lipoprotein lipase and dyslipidemia in systemic lupus erythematosus.
Reichlin M; Fesmire J; Quintero-Del-Rio AI; Wolfson-Reichlin M
Arthritis Rheum; 2002 Nov; 46(11):2957-63. PubMed ID: 12428237
[TBL] [Abstract][Full Text] [Related]
42. Elevated serum autoantibodies against co-inhibitory PD-1 facilitate T cell proliferation and correlate with disease activity in new-onset systemic lupus erythematosus patients.
Shi H; Ye J; Teng J; Yin Y; Hu Q; Wu X; Liu H; Cheng X; Su Y; Liu M; Gu J; Lu T; Chen H; Zheng H; Sun Y; Yang C
Arthritis Res Ther; 2017 Mar; 19(1):52. PubMed ID: 28274252
[TBL] [Abstract][Full Text] [Related]
43. Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-gamma and anti-double-stranded DNA antibody production.
Kawamoto M; Harigai M; Hara M; Kawaguchi Y; Tezuka K; Tanaka M; Sugiura T; Katsumata Y; Fukasawa C; Ichida H; Higami S; Kamatani N
Arthritis Res Ther; 2006; 8(3):R62. PubMed ID: 16563187
[TBL] [Abstract][Full Text] [Related]
44. The effect of adherent cell-derived factors on immunoglobulin and anti-DNA synthesis in systemic lupus erythematosus.
Jandl RC; George JL; Silberstein DS; Eaton RB; Schur PH
Clin Immunol Immunopathol; 1987 Mar; 42(3):344-59. PubMed ID: 3493867
[TBL] [Abstract][Full Text] [Related]
45. Anti-lymphocyte antibodies in systemic lupus erythematosus.
Winfield JB
Clin Rheum Dis; 1985 Dec; 11(3):523-49. PubMed ID: 3907954
[TBL] [Abstract][Full Text] [Related]
46. Studies of anti-lymphocyte antibody in patients with active SLE. II. Effect of anti-lymphocyte antibody on autoreactive cell clones.
Morimoto C; Abe T; Toguchi T; Kiyotaki M; Homma M
Scand J Immunol; 1980; 11(5):479-88. PubMed ID: 6966821
[TBL] [Abstract][Full Text] [Related]
47. Autostimulatory effects of IL-6 on excessive B cell differentiation in patients with systemic lupus erythematosus: analysis of IL-6 production and IL-6R expression.
Kitani A; Hara M; Hirose T; Harigai M; Suzuki K; Kawakami M; Kawaguchi Y; Hidaka T; Kawagoe M; Nakamura H
Clin Exp Immunol; 1992 Apr; 88(1):75-83. PubMed ID: 1563109
[TBL] [Abstract][Full Text] [Related]
48. CD8+ lymphocytes from patients with systemic lupus erythematosus sustain, rather than suppress, spontaneous polyclonal IgG production and synergize with CD4+ cells to support autoantibody synthesis.
Linker-Israeli M; Quismorio FP; Horwitz DA
Arthritis Rheum; 1990 Aug; 33(8):1216-25. PubMed ID: 1975176
[TBL] [Abstract][Full Text] [Related]
49. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement.
Lopez LR; Simpson DF; Hurley BL; Matsuura E
Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973
[TBL] [Abstract][Full Text] [Related]
50. Presence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus.
Cines DB; Lyss AP; Reeber M; Bina M; DeHoratius RJ
J Clin Invest; 1984 Mar; 73(3):611-25. PubMed ID: 6368583
[TBL] [Abstract][Full Text] [Related]
51. Mechanism of spontaneous activation of B cells in patients with systemic lupus erythematosus. Analysis with anti-class II antibody.
Tanaka Y; Shirakawa F; Ota T; Suzuki H; Eto S; Yamashita U
J Immunol; 1988 Feb; 140(3):761-7. PubMed ID: 3276779
[TBL] [Abstract][Full Text] [Related]
52. The effect of interleukin-10 and of interleukin-12 on the in vitro production of anti-double-stranded DNA antibodies from patients with systemic lupus erythematosus.
Tyrrell-Price J; Lydyard PM; Isenberg DA
Clin Exp Immunol; 2001 Apr; 124(1):118-25. PubMed ID: 11359450
[TBL] [Abstract][Full Text] [Related]
53. In vitro inhibition of anti-DNA producing cells from systemic lupus erythematosus patients by autologous anti-F(ab')2 antibodies.
Silvestris F; Williams RC; Frassanito MA; Dammacco F
Clin Immunol Immunopathol; 1987 Jan; 42(1):50-62. PubMed ID: 3491713
[TBL] [Abstract][Full Text] [Related]
54. Antibodies against polyriboadenylic acid in systemic lupus erythematosus and rheumatoid arthritis demonstrated by ELISA. Prevalence of and relation to antibodies against DNA and extractable nuclear antigens.
Gripenberg M; Piirainen H; Linder E
Scand J Rheumatol; 1981; 10(1):33-7. PubMed ID: 6971488
[TBL] [Abstract][Full Text] [Related]
55. Selective adsorption of antiphospholipid and anti-dsDNA autoantibodies on histidine based pseudobioaffinity adsorbent from sera of patients with systemic lupus erythematosus (SLE).
Zeinab M; Hiam KM; Edmond C; Assem E
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jan; 975():77-83. PubMed ID: 25438246
[TBL] [Abstract][Full Text] [Related]
56. IgG anti-lymphocyte antibodies in systemic lupus erythematosus react with surface molecules shared by peripheral T cells and a primitive T cell line.
Minota S; Winfield JB
J Immunol; 1987 Mar; 138(6):1750-6. PubMed ID: 3102598
[TBL] [Abstract][Full Text] [Related]
57. Isotype and cytotoxicity spectra of anti-lymphocyte antibodies in patients with systemic lupus erythematosus.
Edwards BS; Searles RP; Brozek CM; Richards R; Savage SM; Nolla H; Hoffman CL
Clin Immunol Immunopathol; 1987 Dec; 45(3):333-47. PubMed ID: 3315337
[TBL] [Abstract][Full Text] [Related]
58. The in vitro production and regulation of anti-double stranded DNA antibodies by peripheral blood mononuclear cells from normals and patients with systemic lupus erythematosus.
Mach PS; Kharouby M; Lutcher F; Olivier JL; Bazely N; Dougados M; Amor B
Clin Exp Immunol; 1984 Aug; 57(2):338-44. PubMed ID: 6331922
[TBL] [Abstract][Full Text] [Related]
59. The in vitro production of anti-DNA antibody by cultured peripheral blood or tonsillar lymphoid cells from normal donors and SLE patients.
Cairns E; St Germain J; Bell DA
J Immunol; 1985 Dec; 135(6):3839-44. PubMed ID: 3905965
[TBL] [Abstract][Full Text] [Related]
60. Elevated oxidized lipids, anti-lipid autoantibodies and oxidized lipid immune complexes in active SLE.
Ye Y; Wu T; Zhang T; Han J; Habazi D; Saxena R; Mohan C
Clin Immunol; 2019 Aug; 205():43-48. PubMed ID: 31075396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
